What insurance policy changes affect code Q53.9?

There are 3 tracked policy changes affecting code Q53.9, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code Q53.9?

Payers that have issued tracked updates for code Q53.9 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code Q53.9 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code Q53.9. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code Q53.9?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

Q53.9 Insurance Policy Changes

ICD-10 Q53.9 is officially defined as "Undescended testicle, unspecified." code Q53.9 is referenced in 3 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code Q53.9 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Effective Aug 12, 2025Medium impact
Human Chorionic Gonadotropin (hCG) (CPB 1081, reviewed 2026-10-08)
Aetna considers chorionic gonadotropin products (Novarel, Pregnyl, Ovidrel and generic hCG) medically necessary for induction of oocyte maturation or release in assisted reproductive technology or ovulation induction, prepubertal cryptorchidism not due to anatomical obstruction, hypogonadotropic hypogonadism meeting listed criteria for inducing spermatogenesis, and steroid-refractory acute graft-versus-host disease under listed conditions. Use for endometrium preparation alone for frozen embryo transfer, idiopathic male infertility, idiopathic microphallus and obesity or weight loss is considered experimental, investigational or unproven.
Aetna · Identified Aug 16, 2026Medium impact
Scrotal Ultrasonography (CPB 0532, reviewed 2026-07-29)
Aetna considers scrotal ultrasonography (CPT 76870) medically necessary for scrotal mass lesions or tumors, undescended testes in the situations the policy lists, suspected testicular torsion, hydroceles, evaluation of infertile men, acute scrotal pain or swelling, scrotal injury or trauma, and varicoceles. Aetna considers it experimental, investigational, or unproven for other indications, including the initial evaluation for infertility unless physical examination of the scrotum is difficult or inadequate or a testicular mass is suspected, and surveillance of testicular microlithiasis in the absence of additional risk factors.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Human Chorionic Gonadotropin
Novarel (gonadotropin, chorionic) and Pregnyl (choriogonadotropin alfa) require prior authorization under this BCBSMS policy and are medically necessary for hypogonadism secondary to a pituitary deficiency and for prepubertal cryptorchidism not due to anatomical obstruction. Services and supplies related to infertility, artificial insemination, intrauterine insemination and in-vitro fertilization are non-covered regardless of any claim of medical necessity. The use of samples does not count as current or stable therapy. The most recent update, dated 05/26/2026, left the policy statements unchanged and removed ICD-9 procedure and diagnosis codes from the code reference.

Watch Q53.9

Get one email when a payer policy names Q53.9, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Human Chorionic Gonadotropin (hCG) (CPB 1081, reviewed 2026-10-08)

Scrotal Ultrasonography (CPB 0532, reviewed 2026-07-29)

Human Chorionic Gonadotropin

What insurance policy changes affect code Q53.9?

Which payers have updated policy for code Q53.9?

How do I get notified when code Q53.9 policy changes?

Why do payers change policies for code Q53.9?